Award
National Heart, Lung, and Blood Institute 5K23HL169929-03
Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD Trial
Recipient
Not Specified
Award Amount
$156,087.00
Ceiling
$156,087.00
Awarded
May 04, 2026
Identifier
5K23HL169929-03
Award for a clinical trial to evaluate the EMERALD intervention for hyperlipidemia in emergency departments, funded by NHLBI for $156,087 starting April 2026.
Description
This project involves a clinical trial to evaluate the efficacy of the EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) intervention for hyperlipidemia in emergency department settings. The award is funded by NHLBI, with a total amount of $156,087, and is scheduled to start in April 2026. The project aims to develop and implement preventive cardiovascular care strategies for high cholesterol patients presenting with chest pain in emergency departments.